Details
| Originalsprache | Englisch |
|---|---|
| Seiten (von - bis) | 3000-3003 |
| Seitenumfang | 4 |
| Fachzeitschrift | Organic Letters |
| Jahrgang | 16 |
| Ausgabenummer | 11 |
| Publikationsstatus | Veröffentlicht - 29 Mai 2014 |
Abstract
The synthesis of a new ansamycin macrolactam derivative that contains an ansa chain based on ansamitocin and an aromatic core related to geldanamycin is reported. The selective introduction of the cyclic carbamoyl group at C7 and C9 relies on a biotransformation using a mutant strain of S. hygroscopicus, the geldanamycin producer. The ansamycin hybrid forms atropisomers that differ in their antiproliferative activity toward cancer cells.
ASJC Scopus Sachgebiete
- Biochemie, Genetik und Molekularbiologie (insg.)
- Biochemie
- Chemie (insg.)
- Physikalische und Theoretische Chemie
- Chemie (insg.)
- Organische Chemie
Ziele für nachhaltige Entwicklung
Zitieren
- Standard
- Harvard
- Apa
- Vancouver
- BibTex
- RIS
in: Organic Letters, Jahrgang 16, Nr. 11, 29.05.2014, S. 3000-3003.
Publikation: Beitrag in Fachzeitschrift › Artikel › Forschung › Peer-Review
}
TY - JOUR
T1 - Synthesis of a cytotoxic ansamycin hybrid
AU - Jürjens, Gerrit
AU - Kirschning, Andreas
PY - 2014/5/29
Y1 - 2014/5/29
N2 - The synthesis of a new ansamycin macrolactam derivative that contains an ansa chain based on ansamitocin and an aromatic core related to geldanamycin is reported. The selective introduction of the cyclic carbamoyl group at C7 and C9 relies on a biotransformation using a mutant strain of S. hygroscopicus, the geldanamycin producer. The ansamycin hybrid forms atropisomers that differ in their antiproliferative activity toward cancer cells.
AB - The synthesis of a new ansamycin macrolactam derivative that contains an ansa chain based on ansamitocin and an aromatic core related to geldanamycin is reported. The selective introduction of the cyclic carbamoyl group at C7 and C9 relies on a biotransformation using a mutant strain of S. hygroscopicus, the geldanamycin producer. The ansamycin hybrid forms atropisomers that differ in their antiproliferative activity toward cancer cells.
UR - http://www.scopus.com/inward/record.url?scp=84902105425&partnerID=8YFLogxK
U2 - 10.1021/ol5011278
DO - 10.1021/ol5011278
M3 - Article
C2 - 24874463
AN - SCOPUS:84902105425
VL - 16
SP - 3000
EP - 3003
JO - Organic Letters
JF - Organic Letters
SN - 1523-7060
IS - 11
ER -